Ryoko Horigome

Concurrent partial splenic embolization with transcatheter arterial chemoembolization for hepatocellular carcinoma can maintain hepatic functional reserve

Toru Ishikawa, Tomoyuki Kubota, Ryoko Horigome et al. · Hepatology Research · 2013 · 21 citations · Full text

Medicine, Hematology, Oncology +16

Efficacy and safety of repeated use of lusutrombopag prior to radiofrequency ablation in patients with recurrent hepatocellular carcinoma and thrombocytopenia

Toru Ishikawa, Marina Okoshi, Kei Tomiyoshi et al. · Hepatology Research · 2019 · 21 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Branched-chain amino acids to tyrosine ratio (BTR) predicts intrahepatic distant recurrence and survival for early hepatocellular carcinoma.

Toru Ishikawa, Tomoyuki Kubota, Ryoko Horigome et al. · PubMed · 2014 · 11 citations

Medicine, Oncology, Clinical Biochemistry +16

Overexpression of a disintegrin and metalloproteinase 21 is associated with motility, metastasis, and poor prognosis in hepatocellular carcinoma

Hiroki Honda, Masaaki Takamura, Satoshi Yamagiwa et al. · Scientific Reports · 2017 · 10 citations · Full text

Medicine, Molecular Biology, Oncology +17